3
Pre Screening
Our expert nurses check clinical trials and contact you
If you have refractory or relapsed mantle cell lymphoma (MCL), joining a clinical trial may be your best choice.
Mantle Cell Lymphoma Clinical Trials
Massive Bio has onboarded over 160,000 cancer patients to find their clinical trial
Looking for a mantle cell lymphoma clinical trial can be difficult. Massive Bio’s advanced artificial intelligence (AI) platform can assist you in this long process for free! We will recommend clinical trial options in mantle cell lymphoma (MCL) clinical trials that match your conditions and clinical characteristics specifically. Once you submit your medical condition information, our oncology informatics experts will review your MCL case and contact you for eligibility.
Understanding your full range of options for an improved quality of life is crucial when facing a refractory or relapsed mantle cell lymphoma diagnosis. This is particularly true after receiving chemotherapy and targeted approaches like anti-CD20 or BTKi .
Our cutting-edge clinical trials for early or advanced stages of lymphoma aim to explore new, targeted options designed specifically for patients like you – for free.
We are pleased to offer you the chance to participate in a new therapy for Mantle Cell Lymphoma, a type of non-Hodgkin’s lymphoma. This therapy for b-cell malignancies has shown encouraging results.
By signing up for this blood cancer trial matching program, you’ll be provided with a personalized option specifically tailored to your medical needs.
When you register for our matching service, we’ll help you find clinical trials for free that are a good fit for your situation. Here’s how it works:
Diagnosis: If you have been diagnosed with Mantle Cell Lymphoma that continue to progress in spite of option or that has come back and spread to other parts of the body, you might now have a new option in finding a potential clinical trial.
Innovative Approach: Our advanced AI brings together the latest developments in medical science and technology to accurately.
Personalized Match: We understand that every patient is unique, which is why we tailor plans to align with your specific requirements and medical history, whether you’re dealing with mantle cell lymphoma that has spread to the lymphatic system of the body or has relapsed.
Expert Guidance: Throughout your journey, even with a relapsed or refractory MCL, our experienced team of medical professionals will be by your side. We will be providing guidance, support, and answering any questions you may have.
1st Line Anti-CD20 and 1st Line BTKi Approach: If you have been diagnosed with MCL, it is possible that you have received 1st line anti-CD20 therapy and first line BTKi approach as part of your regimen. Anti-CD20 antibodies such us rituximab, target a protein called CD20 on the surface of cancerous cells, helping to destroy them. BTK inhibitors such as acalabrutinib, zanubrutinib, or ibrutinib work by blocking a protein called Bruton’s Tyrosine Kinase (BTK), which plays a role in the growth and survival of lymphoma cells. If these medications haven’t been effective for you, it suggests that your condition is either refractory or has relapsed. This makes you a potential candidate for participation in this trial.
What is Mantle Cell Lymphoma?
Mantle cell lymphoma (MCL) is a relatively rare form of non-Hodgkin lymphoma, representing about 6% of non-Hodgkin lymphoma cases. The life expectancy and survival rates for patients with MCL can vary widely, influenced by factors such as the stage of the disease, overall health, age, and response to treatment.
The median life expectancy for mantle cell lymphoma is often reported to be around 5 to 7 years. However, it’s crucial to note that this is a median, meaning that many patients can live significantly longer, particularly those who are otherwise healthy and respond well to treatment to Car-T Cell therapies . The survival rate for MCL is a statistical measure based on larger population groups and does not necessarily predict the outcome for an individual patient. Some patients might live much longer than these median estimates, while others might have a shorter survival time.
By signing up for our matching program, you’re taking an active role in exploring new possibilities and gaining access to an innovative therapy that can potentially transform your life.
Join us today and let’s embark on this extraordinary path towards improved health together!
Cancer is an unfortunate reality that touches most of us at some point in our lives. If you or a loved one has cancer, you may have heard or read that clinical trials could offer access to innovative new options. But what exactly is a clinical trial? In this video, Massive Bio co-founder Arturo Loaiza-Bonilla, MD, explains how clinical trials work, what to expect if you enroll in one, and why a clinical trial can be an important option for many cancer patients.
We dream of the day when cancer disappears from our lives. Massive Bio is working tirelessly on achieving that goal.
Explore Innovative Mantle Cell Lymphoma Clinical Trials
Looking for a mantle cell lymphoma clinical trial can be difficult. Massive Bio’s advanced artificial intelligence (AI) platform can assist you in this long process for free! We will recommend clinical trial options in mantle cell lymphoma (MCL) clinical trials that match your conditions and clinical characteristics specifically. Once you submit your medical condition information, our oncology informatics experts will review your MCL case and contact you for eligibility.
Understanding your full range of options for an improved quality of life is crucial when facing a refractory or relapsed mantle cell lymphoma diagnosis. This is particularly true after receiving chemotherapy and targeted approaches like anti-CD20 or BTKi .
Our cutting-edge clinical trials for early or advanced stages of lymphoma aim to explore new, targeted options designed specifically for patients like you – for free.
We are pleased to offer you the chance to participate in a new therapy for Mantle Cell Lymphoma, a type of non-Hodgkin’s lymphoma. This therapy for b-cell malignancies has shown encouraging results.
By signing up for this blood cancer trial matching program, you’ll be provided with a personalized option specifically tailored to your medical needs.
When you register for our matching service, we’ll help you find clinical trials for free that are a good fit for your situation. Here’s how it works:
Diagnosis: If you have been diagnosed with Mantle Cell Lymphoma that continue to progress in spite of option or that has come back and spread to other parts of the body, you might now have a new option in finding a potential clinical trial.
Innovative Approach: Our advanced AI brings together the latest developments in medical science and technology to accurately.
Personalized Match: We understand that every patient is unique, which is why we tailor plans to align with your specific requirements and medical history, whether you’re dealing with mantle cell lymphoma that has spread to the lymphatic system of the body or has relapsed.
Expert Guidance: Throughout your journey, even with a relapsed or refractory MCL, our experienced team of medical professionals will be by your side. We will be providing guidance, support, and answering any questions you may have.
1st Line Anti-CD20 and 1st Line BTKi Approach: If you have been diagnosed with MCL, it is possible that you have received 1st line anti-CD20 therapy and first line BTKi approach as part of your regimen. Anti-CD20 antibodies such us rituximab, target a protein called CD20 on the surface of cancerous cells, helping to destroy them. BTK inhibitors such as acalabrutinib, zanubrutinib, or ibrutinib work by blocking a protein called Bruton’s Tyrosine Kinase (BTK), which plays a role in the growth and survival of lymphoma cells. If these medications haven’t been effective for you, it suggests that your condition is either refractory or has relapsed. This makes you a potential candidate for participation in this trial.
Understanding the disease
What is Mantle Cell Lymphoma?
Mantle cell lymphoma (MCL) is a relatively rare form of non-Hodgkin lymphoma, representing about 6% of non-Hodgkin lymphoma cases. The life expectancy and survival rates for patients with MCL can vary widely, influenced by factors such as the stage of the disease, overall health, age, and response to treatment.
The median life expectancy for mantle cell lymphoma is often reported to be around 5 to 7 years. However, it’s crucial to note that this is a median, meaning that many patients can live significantly longer, particularly those who are otherwise healthy and respond well to treatment to Car-T Cell therapies . The survival rate for MCL is a statistical measure based on larger population groups and does not necessarily predict the outcome for an individual patient. Some patients might live much longer than these median estimates, while others might have a shorter survival time.
By signing up for our matching program, you’re taking an active role in exploring new possibilities and gaining access to an innovative therapy that can potentially transform your life.
Join us today and let’s embark on this extraordinary path towards improved health together!
Dr. Arturo Loaiza Bonilla explains:
What Are Clinical Trials?Cancer is an unfortunate reality that touches most of us at some point in our lives. If you or a loved one has cancer, you may have heard or read that clinical trials could offer access to innovative new options. But what exactly is a clinical trial? In this video, Massive Bio co-founder Arturo Loaiza-Bonilla, MD, explains how clinical trials work, what to expect if you enroll in one, and why a clinical trial can be an important option for many cancer patients.
We dream of the day when cancer disappears from our lives. Massive Bio is working tirelessly on achieving that goal.
An mantle cell lymphoma cancer clinical trial may be an option for you
1
Consent Signed
Fill out our contact form and sign our consent form
2
Data Collection
We collect your medical records securely
3
Pre Screening
Our expert nurses check clinical trials and contact you
4
Concierge Services
We support you with appointments, travel, and accommodation
Ancervical mantle cell lymphoma cancer clinical trial may be an option for you
4
Concierge Services
We support you with appointments, travel, and accommodation
1
Consent Signed
Fill out our contact form and sign our consent form
2
Data Collection
We collect your medical records securely
3
Pre Screening
Our expert nurses check clinical trials and contact you
4
Concierge Services
We support you with appointments, travel, and accommodation
1
Consent Signed
Fill out our contact form and sign our consent form
2
Data Collection
We collect your medical records securely
Let’s explore your options and bring new hope to your journey.
We offer a quick, easy and FREE way to find mantle cell lymphoma cancer clinical research opportunities for patients like you. With our unique clinical trial matching system (CTMS) and team specialized in oncology, we can rapidly match you to a clinical research study for those diagnosed with mantle cell lymphoma cancer.
Frequently asked questions
To enroll in clinical trial, you must meet highly specific criteria that’s established by the researchers who are conducting the investigation. That includes detailed information about type of cancer, treatment history, response to treatment, and other data that is collected in medical records.
If you are being treated for cancer or any other disease, your doctor should have a complete record of your medical care, including specific information about what form of the disease you have and what treatments you have received. Your patient relations coordinator will contact you and inform you about the details.
Massive Bio provides its services to the patients and their doctors at no cost—you won’t have to pay anything to receive a clinical-research matching report. There are no hidden costs involved.
Massive Bio strictly adheres to all HIPAA guidelines and international regulations focused on maintaining your privacy. We take extra measures to secure your personal information, ensuring it is protected beyond the mandatory requirements.
Your doctor may know of a clinical research study being conducted in your area that’s recruiting participants and is right for you. However, Massive Bio uses its artificial intelligence powered platform to match patients to clinical research studies that give you the best chance of a positive outcome and are being conducted in a geographical location that makes sense for you.
Yes, Massive Bio keeps your doctor up to date on your status throughout your participation.